End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 THB | -3.60% |
|
-14.40% | 0.00% |
Valuation
Fiscal Period: December | 2024 |
---|---|
Capitalization 1 | 1,284 |
Enterprise Value (EV) 1 | 1,284 |
P/E ratio | - |
Yield | 1.87% |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | - |
EV / FCF | - |
FCF Yield | - |
Price to Book | 1.73 x |
Nbr of stocks (in thousands) | 600,000 |
Reference price 2 | 2.140 |
Announcement Date | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2023 | 2024 |
---|---|---|
Net sales | - | - |
EBITDA | - | - |
EBIT | - | - |
Operating Margin | - | - |
Earnings before Tax (EBT) | - | - |
Net income | 32.14 | - |
Net margin | - | - |
EPS | 0.0700 | - |
Free Cash Flow | - | - |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share 1 | - | 0.0400 |
Announcement Date | 3/19/24 | - |
Balance Sheet Analysis
Fiscal Period: December | 2023 | 2024 |
---|---|---|
Net Debt | - | - |
Net Cash position | - | - |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | - |
ROE (net income / shareholders' equity) | - | - |
ROA (Net income/ Total Assets) | - | - |
Assets | - | - |
Book Value Per Share 1 | - | 1.240 |
Cash Flow per Share | - | - |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 3/19/24 | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 36.87M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- BKGI Stock
- Financials Bangkok Genomics Innovation